1840nok
-3,9 %
Date:2025-08-01Time:18:00:00Latest report:Q1-2025List:Oslo BorsTicker:AZT
Market Cap:940 mnokEnterprise Value:779 mnokNet Sales:99,5 mnokEarnings:1,29 mnokEmployees:0ISIN:NO0010014632

Ratios

10-year key figure history for ArcticZymes turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ArcticZymes with index and moving average MA50 and MA200.

Stockprice:18,40
MA50:16,81
MA200:15,99
Price/MA200:15,1 %
RSI (14):60,1
Price/MA50:9,5 %

Description

ArcticZymes Technologies is active in biotechnology. The company specializes in research and development of drugs for the treatment of autoimmune diseases. The main focus is on the development of glucans, the production of immunostimulants, and the analysis of enzymes. The vision is to test and develop the medicine and then further use it for RNA and DNA processes. The company was previously known as Biotec Pharmacon and is headquartered in Tromsø.

Biotechnology